Cancer risk and genotype–phenotype correlation in Japanese patients with Cowden syndrome Satoshi TeramaeNaoki MugurumaTetsuji Takayama Original Article 02 February 2022 Pages: 639 - 647
Male patients with papillary thyroid cancer have a higher risk of extranodal extension Hu HeiBin ZhouJianwu Qin Original Article 08 January 2022 Pages: 648 - 654
Prognostic laboratory score to predict 14-day mortality in terminally ill patients with respiratory malignancy Mari TanakaNatsuko KawaiNorihiro Yuasa Original Article 23 January 2022 Pages: 655 - 664
Mapping of global, regional and national incidence, mortality and mortality-to-incidence ratio of lung cancer in 2020 and 2050 Rajesh Sharma Original Article 12 January 2022 Pages: 665 - 675
Phase II study of carboplatin–paclitaxel alone or with bevacizumab in advanced sarcomatoid carcinoma of the lung: HOT1201/NEJ024 Satoshi OizumiKei TakamuraNorth East Japan Study Group, Hokkaido Lung Cancer Clinical Study Group Original Article 29 January 2022 Pages: 676 - 683
Nanoparticle albumin-bound paclitaxel and ramucirumab versus paclitaxel and ramucirumab as second-line chemotherapy for unresectable advanced or recurrent gastric cancer: a multicenter, propensity score-matched analysis (CROSS SELL study) Akio NakasyaYuya HagiwaraIchinosuke Hyodo Original Article Open access 28 January 2022 Pages: 684 - 694
First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in advanced non-small cell lung cancer: a subanalysis of Asian patients in CheckMate 9LA Thomas JohnHiroshi SakaiShun Lu Original Article Open access 19 February 2022 Pages: 695 - 706
The impact of hormone receptor on the clinical outcomes of HER2-positive breast cancer: a population-based study Yiqun HanYun WuBinghe Xu Original Article Open access 18 January 2022 Pages: 707 - 716
Novel combined fibrosis-based index predicts the long-term outcomes of hepatocellular carcinoma after hepatic resection Mitsuru YanagakiYoshihiro ShiraiToru Ikegami Original Article 11 January 2022 Pages: 717 - 728
Relationship between psoas muscle index and long-term survival in older patients aged ≥ 80 years after endoscopic submucosal dissection for gastric cancer Nobuhito ItoKohei FunasakaMitsuhiro Fujishiro Original Article 11 January 2022 Pages: 729 - 738
Dual hepatitis B and C-associated hepatocellular carcinoma: clinical characteristics, outcome, and prognostic role of albumin–bilirubin grade Chih-Chieh KoShu-Yein HoTeh-Ia Huo Original Article 04 February 2022 Pages: 739 - 748
Clinicopathological and molecular characteristics of early-onset vs late-onset colorectal cancer according to tumor location Yongle ChenZexian ChenXiaosheng He Original Article 26 January 2022 Pages: 749 - 755
Proposal for a tumor budding predictive score derived from endoscopic biopsy samples in colorectal cancer Masato YamaderaEiji ShintoHideki Ueno Original Article 29 January 2022 Pages: 756 - 764
Hormone replacement therapy in relation to the risk of colorectal cancer in women by BMI: a multicentre study with propensity score matching Lingkai XuLin LiXiaochen Shu Original Article 13 January 2022 Pages: 765 - 773
Novel diagnostic model for bone metastases in renal cell carcinoma patients based on bone scintigraphy analyzed by computer-aided diagnosis software and bone turnover markers Takeshi UjikeMotohide UemuraNorio Nonomura Original Article Open access 04 February 2022 Pages: 774 - 780
Extent of pelvic lymph node dissection improves early oncological outcomes for patients with high-risk prostate cancer without lymph node involvement after robot-assisted radical prostatectomy Shuichi MorizaneMasashi HondaAtsushi Takenaka Original Article 25 January 2022 Pages: 781 - 789
Platinum rechallenge treatment using gemcitabine plus carboplatin with or without bevacizumab for platinum-resistant ovarian cancer Hiroki NasuShin NishioKimio Ushijima Original Article 05 January 2022 Pages: 790 - 801
Role of adjuvant chemotherapy in patients with localized, undifferentiated pleomorphic sarcoma of soft tissue: a population-based cohort study Hiroshi KobayashiLiuzhe ZhangSakae Tanaka Original Article 22 January 2022 Pages: 802 - 810
CircRNA PVT1 promotes proliferation and chemoresistance of osteosarcoma cells via the miR-24-3p/KLF8 axis Bin WangLifang YanWeiguo Liang Original Article 16 February 2022 Pages: 811 - 822
Correction to: Osimertinib in poor performance status patients with T790M‑positive advanced non‑small‑cell lung cancer after progression of first- and second‑generation EGFR‑TKI treatments (NEJ032B) Yukari TsubataKana WatanabeTakeshi Isobe Correction 08 March 2022 Pages: 823 - 824
Correction to: Indications for fertility preservation not included in the 2017 Japan Society of Clinical Oncology Guideline for Fertility Preservation in Pediatric, Adolescent, and Young Adult Patients treated with gonadal toxicity, including benign diseases Masanori OnoKimikazu MatsumotoNao Suzuki Correction Open access 21 February 2022 Pages: 825 - 826
Correction to: The impact of complications after initial prostate biopsy on repeat protocol biopsy acceptance rate. Results from the Prostate Cancer Research International: Active Surveillance JAPAN study Yoichiro TohiTakuma KatoMikio Sugimoto Correction 03 March 2022 Pages: 827 - 827